$8.8MSeed, 3 March 2026
Seed proceeds fund industrial-scale RNA-seq; company also named a new CEO.
- Amount
- $8.8M
- Stage
- Seed
- Announced
- 3 March 2026
- Lead
- Genku Ventures
- Use of funds
- Seed proceeds fund industrial-scale RNA-seq; company also named a new CEO.
- Checked
- Announced by the company
- Source
- Alithea Genomics closes CHF 6.9M seed round businesswire.com